The implication of TGFBR3 in the inhibition of the NF-κB pathway and cellular migration via the interaction with β-arrestin 2 has also been demonstrated in MCF10A breast epithelial and MDA-MB-231 breast cancer cells [137]. The gene discussed is TGFBR3; the disease is breast carcinoma.